How Safely and for How Long Can Warfarin Therapy Be Withheld in Prosthetic Heart Valve Patients Hospitalized With a Major Hemorrhage?
- 1 February 2001
- Vol. 119 (2) , 478-484
- https://doi.org/10.1378/chest.119.2.478
Abstract
No abstract availableKeywords
This publication has 38 references indexed in Scilit:
- Prosthetic Heart ValvesNew England Journal of Medicine, 1996
- Management of intracranial hemorrhage associated with anticoagulant therapySurgical Neurology, 1995
- Optimal Oral Anticoagulant Therapy in Patients with Mechanical Heart ValvesNew England Journal of Medicine, 1995
- Thromboembolic and bleeding complications in patients with mechanical heart valve prostheses.Circulation, 1994
- Bleeding Complications in Oral Anticoagulant TherapyArchives of internal medicine (1960), 1993
- Risk Factors for Complications of Chronic Anticoagulation: A Multicenter StudyAnnals of Internal Medicine, 1993
- Anticoagulant-related Intracerebral Hemorrhage in Patients with Prosthetic Heart ValvesNeurologia medico-chirurgica, 1991
- Major bleeding in outpatients treated with warfarin: incidence and prediction by factors known at the start of outpatient therapyThe American Journal of Medicine, 1989
- Duration of warfarin anticoagulant therapy and the probabilities of recurrent thromboembolism and hemorrhageThe American Journal of Medicine, 1986
- Thromboembolic Complications of Current Cardiac Valvular ProsthesesThe Annals of Thoracic Surgery, 1982